127 related articles for article (PubMed ID: 6112877)
1. A familial glucagonoma syndrome: genetic, clinical and biochemical features.
Stacpoole PW; Jaspan J; Kasselberg AG; Halter SA; Polonsky K; Gluck FW; Liljenquist JE; Rabin D
Am J Med; 1981 May; 70(5):1017-26. PubMed ID: 6112877
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
[TBL] [Abstract][Full Text] [Related]
3. Multiple hormone secretion by a human pancreatic glucagonoma in culture.
White A; Tan K; Gray C; Roberts I; Ratcliffe JG
Regul Pept; 1985 Aug; 11(4):335-45. PubMed ID: 2864720
[TBL] [Abstract][Full Text] [Related]
4. [Glucagonoma syndrome in a multihormonal pancreatic tumor].
Keller U; Fankhauser S; Schumacher A; Trimble ER; Heitz PU
Schweiz Med Wochenschr; 1982 Feb; 112(9):297-304. PubMed ID: 6281878
[TBL] [Abstract][Full Text] [Related]
5. Metabolic studies and glucagon gel filtration pattern before and after surgery in a case of glucagonoma syndrome.
von Schenck H; Thorell JI; Berg J; Bojs G; Dymling JF; Hallengren B; Ljungberg O; Tibblin S
Acta Med Scand; 1979; 205(3):155-62. PubMed ID: 218426
[TBL] [Abstract][Full Text] [Related]
6. A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome.
Fujita J; Seino Y; Ishida H; Taminato T; Matsukura S; Horio T; Imamura S; Naito A; Tobe T; Takahashi K
Cancer; 1986 Feb; 57(4):860-5. PubMed ID: 2867823
[TBL] [Abstract][Full Text] [Related]
7. Insulin and somatostatin releasing islet cell tumor caused hypoglycemia.
Karasawa Y; Mochizuki T; Kawa S; Aoki Y; Ueno T; Watanabe T; Kawasaki S; Miyagawa S; Itoh N; Tamai C; Sakurai A; Kiyosawa K
Intern Med; 2001 Apr; 40(4):324-30. PubMed ID: 11334393
[TBL] [Abstract][Full Text] [Related]
8. Primary endocrine-secreting pancreatic tumors.
Macaron C
Am Fam Physician; 1980 Apr; 21(4):94-8. PubMed ID: 6103668
[TBL] [Abstract][Full Text] [Related]
9. [An autopsy case of glucagonoma associated with production of several hormones].
Fujise K; Matsuura T; Nakagawa J; Egawa K; Hihara M; Nakahara M; Kawase H; Kitahara T; Ohara K; Joh K
Nihon Naika Gakkai Zasshi; 1988 Jun; 77(6):880-1. PubMed ID: 2906354
[No Abstract] [Full Text] [Related]
10. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
Torre L; Vazquez JA; Blázquez E
Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
[TBL] [Abstract][Full Text] [Related]
11. A malignant insulinoma transformed into a glucagonoma syndrome.
Ohneda A; Otsuki M; Fujiya H; Yaginuma N; Kokubo T; Ohtani H
Diabetes; 1979 Nov; 28(11):962-9. PubMed ID: 226443
[No Abstract] [Full Text] [Related]
12. Effects of transplantation and resection of a radiation-induced rat insulinoma on glucose homeostasis and the endocrine pancreas.
Flatt PR; Tan KS; Bailey CJ; Powell CJ; Swanston-Flatt SK; Marks V
Br J Cancer; 1986 Oct; 54(4):685-92. PubMed ID: 2877684
[TBL] [Abstract][Full Text] [Related]
13. Expression of peptide hormone genes in human islet cell tumors.
Philippe J; Powers AC; Mojsov S; Drucker DJ; Comi R; Habener JF
Diabetes; 1988 Dec; 37(12):1647-51. PubMed ID: 2903836
[TBL] [Abstract][Full Text] [Related]
14. The glucagonoma syndrome: surgically curable diabetes.
Higgins GA; Recant L; Fischman AB
Am J Surg; 1979 Jan; 137(1):142-8. PubMed ID: 215044
[No Abstract] [Full Text] [Related]
15. Calcium reverses octreotide inhibition of insulin and glucagon levels in patients with insulinoma and glucagonoma.
Thompson CS; O'Dorisio TM; Woltering EA
Digestion; 1996; 57 Suppl 1():62-8. PubMed ID: 8813473
[TBL] [Abstract][Full Text] [Related]
16. Glucagon secretion during the development of insulin-secreting tumors induced by streptozotocin and nicotinamide.
Yoshino G; Kazumi T; Morita S; Kobayashi N; Terashi K; Baba S
Endocrinol Jpn; 1979 Dec; 26(6):655-60. PubMed ID: 232037
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin inhibition of insulin secretion in insulin-producing tumors.
Scuro LA; Lo Cascio V; Adami S; Galvanini G; Bianchi I; Cominacini L; Corgnati A
Metabolism; 1976 Jun; 25(6):603-9. PubMed ID: 178978
[No Abstract] [Full Text] [Related]
18. In vivo and in vitro effects of somatostatin and insulin on glucagon release in a human glucagonoma.
Waeber G; Gomez F; Chaubert P; Temler E; Chapuis G; Boulat O; Nicod P; Haefliger JA
Clin Endocrinol (Oxf); 1997 May; 46(5):637-42. PubMed ID: 9231061
[TBL] [Abstract][Full Text] [Related]
19. Suppression and stimulation mechanisms controlling glucagon secretion in a case of islet-cell tumor producing glucagon, insulin, and gastrin.
Tiengo A; Fedele D; Marchiori E; Nosadini R; Muggeo M
Diabetes; 1976 May; 25(5):408-12. PubMed ID: 5326
[TBL] [Abstract][Full Text] [Related]
20. Metastatic islet cell tumour with clinical manifestations of insulin and glucagon excess: successful treatment by hepatic artery embolization and chemotherapy.
Lee SM; Forbes A; Williams R
Eur J Surg Oncol; 1988 Jun; 14(3):265-8. PubMed ID: 2836237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
